Skip to main content
. 2016 Apr 12;7(20):28920–28934. doi: 10.18632/oncotarget.8713

Table 2. Deregulated miRNAs in both miRNA-Seq and TaqMan PCR analyses.

miRNA miRNA-Seq
logFC
P-value miRNA TLDA
logFC
P-value
let-7a-2 0.8844 0.0025 let-7a 2.3601 0.000*
let-7a-3 0.4856 3.2638E-264 let-7a 2.3601 0.000*
miR-15b 0.9831 0.0004 miR-15b 2.4022 0.000*
miR-200b 1.0898 0.0072 miR-200b 1.9404 0.000*
miR-21 1.5219 0.0028 miR-21 2.6311 0.001*
miR-155 1.3089 0.0029 miR-155 1.3294 0.010*
miR-486 −1.635 0.0004 miR-486 −3.9434 0.084
miR-181a-1 −1.1444 0.0006 miR-181a −0.8625 0.140
miR-181a-2 −1.1145 0.0002 miR-181a −0.8625 0.140
let-7g 0.8879 0.0015 let-7g 0.3918 0.143
miR-26b 1.0565 0.0009 miR-26b 0.5597 0.224
miR-218-1 −1.6175 0.0001 miR-218 −1.4699 0.386
miR-886 −1.3187 0.0046 miR-886-3p −1.1746 0.482
miR-425 1.6206 0.0076 miR-425-5p 0.1190 0.906

Test sample set: p ≤ 0.01 and FDR ≤ 0.1, as determined by EdgeR software.

Validation sample set: p ≤ 0.01 as determined by Expression Suite software.

*

Statistically significantly deregulated miRNAs identified in both test and validation sets by transcriptome sequencing and TaqMan PCR analyses.